Search Login Register

Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) Summary

Description: A heterogenous group of degenerative syndromes marked by progressive cerebellar dysfunction either in isolation or combined with other neurologic manifestations. Sporadic and inherited subtypes occur. Inheritance patterns include autosomal dominant, autosomal recessive, and X-linked.

Also Known As: Marinesco Sjogren Syndrome; Spinocerebellar Degeneration; Ataxia, Hereditary; Hereditary Ataxia; Syndrome, Marinesco-Sjogren Show All >>

Networked: 206 relevant articles (5 outcomes, 17 trials/studies) for this Disease

Key Drugs and Agents for Spinocerebellar Degenerations

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Thyrotropin-Releasing Hormone (Protirelin) : 2 outcomes 4 studies in 18 results : FDA 2
  2. Amino Acids : 1 outcome in 2 results : FDA 53
  3. Levodopa (L Dopa) : 1 outcome in 1 result : FDA 29 Generic
  4. Carbon Monoxide : 1 outcome in 1 result : IBA
  5. Antibodies : 2 studies in 5 results : IBA
  6. Vitamin E : 1 study in 8 results : FDA 12
  7. Proteins (Proteins, Gene) : 1 study in 5 results : IBA
  8. polyglutamine : 1 study in 5 results : IBA
  9. Taurine : 1 study in 3 results : FDA 2
  10. Oxygen : 1 study in 3 results : IBA
Show All >>

Diseases Related to Spinocerebellar Degenerations

  1. Ataxia (Dyssynergia)
  2. Friedreich Ataxia (Friedreich's Ataxia)
  3. Parkinson Disease (Parkinson's Disease)
  4. Tremor (Tremors)
  5. Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
Show All >>

Key Therapies for Spinocerebellar Degenerations

Efficacy Chart >>
  1. Transplants (Transplant) : 1 study in 1 result
  2. Heterologous Transplantation (Xenotransplantation) : 1 study in 1 result
  3. Anesthesia : 2 results
  4. Activities of Daily Living (ADL) : 2 results
  5. Investigational Therapies (Experimental Therapy) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2010 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.